Basic Information
RNALocate ID: RLID:01001773
RNA Symbol: hsa-miR-132-3p
Localization: Nucleus
RNA Information
RNA Name: hsa-miR-132
RNA ID: miRBase:MIMAT0000426
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 27583637
Tissue/Cell Line: Human neuroblastoma cell line (SK-N-AS)
Method: Confocal fluorescence microscopy|Live cell imaging
Description: miR-132 appears to be localized within the nucleus of the cells, where its concentration is of the order of 1 μM.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001770 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001771 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01001772 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:11001736 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11001737 Exosome Ovarian follicular fluid 22116803
RLID:11001738 Exosome Breast milk 22211110
RLID:11001739 Exosome Brain tissue 23382797
RLID:11001740 Exosome Plasma 23663360
RLID:11001741 Extracellular vesicle HEK-293T cells 22849433
RLID:11001742 Microvesicle Seminal plasma 23539611
RLID:11001743 Microvesicle Follicular fluid 23666971
RLID:11001744 Microvesicle Cerebrospinal fluid 24797360
RLID:11005568 Exosome Peripheral blood 32785072
RLID-D:11000079 Exosome Blood|Endothelial cells|Mast cells
RLID-D:11000354 Microvesicle Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-132-3p Inflammatory bowel disease MNDR-E-MI-11225
MNDR hsa-miR-132-3p Splenic marginal zone lymphoma MNDR-E-MI-11226
MNDR hsa-miR-132-3p Multiple sclerosis chronic progressive MNDR-E-MI-11227
MNDR hsa-miR-132-3p Oral squamous cell carcinoma MNDR-E-MI-11228
MNDR hsa-miR-132-3p Medulloblastoma MNDR-E-MI-11229
MNDR hsa-miR-132-3p High-grade serous ovarian carcinoma MNDR-E-MI-11230
MNDR hsa-miR-132-3p Uterine corpus endometrial carcinoma MNDR-E-MI-11231
MNDR hsa-miR-132-3p Lymphoma MNDR-E-MI-11232
MNDR hsa-miR-132-3p Lymphoma non-hodgkin MNDR-E-MI-11233
MNDR hsa-miR-132-3p Estrogen-receptor positive breast cancer MNDR-E-MI-11234
MNDR hsa-miR-132-3p Estrogen-receptor negative breast cancer MNDR-E-MI-11235
MNDR hsa-miR-132-3p Progesterone-receptor positive breast cancer MNDR-E-MI-11236
MNDR hsa-miR-132-3p Progesterone-receptor negative breast cancer MNDR-E-MI-11237
MNDR hsa-miR-132-3p Her2-receptor positive breast cancer MNDR-E-MI-11238
MNDR hsa-miR-132-3p Anencephaly MNDR-E-MI-11239
MNDR hsa-miR-132-3p Familial temporal lobe epilepsy 3 MNDR-E-MI-11240
MNDR hsa-miR-132-3p Autosomal recessive limb-girdle muscular dystrophy type 2a MNDR-E-MI-11241
MNDR hsa-miR-132-3p Dermatomyositis MNDR-E-MI-11242
MNDR hsa-miR-132-3p Prostate cancer MNDR-E-MI-11243
MNDR hsa-miR-132-3p Chronic lymphocytic leukemia MNDR-E-MI-11244
MNDR hsa-miR-132-3p Gastric cancer MNDR-E-MI-11245
MNDR hsa-miR-132-3p Gastric lymphoma MNDR-E-MI-11246
MNDR hsa-miR-132-3p Alzheimer disease MNDR-E-MI-11247
MNDR hsa-miR-132-3p Bladder cancer MNDR-E-MI-11248
MNDR hsa-miR-132-3p Dysautonomia familial MNDR-E-MI-11249
MNDR hsa-miR-132-3p Facioscapulohumeral muscular dystrophy MNDR-E-MI-11250
MNDR hsa-miR-132-3p Friedreich ataxia MNDR-E-MI-11251
MNDR hsa-miR-132-3p Huntington disease MNDR-E-MI-11252
MNDR hsa-miR-132-3p Chorea MNDR-E-MI-11253
MNDR hsa-miR-132-3p Cardiovascular disease MNDR-E-MI-11254
MNDR hsa-miR-132-3p Lung cancer MNDR-E-MI-11255
MNDR hsa-miR-132-3p Down syndrome MNDR-E-MI-11256
MNDR hsa-miR-132-3p Fragile x syndrome MNDR-E-MI-11257
MNDR hsa-miR-132-3p Parkinson disease MNDR-E-MI-11258
MNDR hsa-miR-132-3p Cognitive dysfunction MNDR-E-MI-11259
MNDR hsa-miR-132-3p Breast cancer MNDR-E-MI-11260
MNDR hsa-miR-132-3p Thyroid cancer MNDR-E-MI-11261
MNDR hsa-miR-132-3p Pituitary neoplasms MNDR-E-MI-11262
MNDR hsa-miR-132-3p Pancreatic cancer MNDR-E-MI-11263
MNDR hsa-miR-132-3p Melanoma MNDR-E-MI-11264
MNDR hsa-miR-132-3p Rectum adenocarcinoma MNDR-E-MI-11265
MNDR hsa-miR-132-3p Nephroblastoma MNDR-E-MI-11266
MNDR hsa-miR-132-3p Colon cancer MNDR-E-MI-11267
MNDR hsa-miR-132-3p Colon adenocarcinoma MNDR-E-MI-11268
MNDR hsa-miR-132-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-11269
MNDR hsa-miR-132-3p Prostate adenocarcinoma MNDR-E-MI-11270
MNDR hsa-miR-132-3p Endometrial carcinoma MNDR-E-MI-11271
MNDR hsa-miR-132-3p Carcinoma ductal breast MNDR-E-MI-11272
MNDR hsa-miR-132-3p Glioblastoma MNDR-E-MI-11273
MNDR hsa-miR-132-3p Glioma MNDR-E-MI-11274
MNDR hsa-miR-132-3p Chronic obstructive pulmonary disease MNDR-E-MI-11275
MNDR hsa-miR-132-3p Oligodendroglioma MNDR-E-MI-11276
MNDR hsa-miR-132-3p Nemaline myopathy MNDR-E-MI-11277
MNDR hsa-miR-132-3p Chordoma MNDR-E-MI-11278
MNDR hsa-miR-132-3p Amyotrophic lateral sclerosis MNDR-E-MI-11279
MNDR hsa-miR-132-3p Epilepsy temporal lobe MNDR-E-MI-11280
MNDR hsa-miR-132-3p Osteosarcoma MNDR-E-MI-11281
MNDR hsa-miR-132-3p Liver neoplasms MNDR-E-MI-11282
MNDR hsa-miR-132-3p Uterine cancer MNDR-E-MI-11283
MNDR hsa-miR-132-3p Gastric adenocarcinoma MNDR-E-MI-11284
MNDR hsa-miR-132-3p Cervical squamous cell carcinoma MNDR-E-MI-11285
MNDR hsa-miR-132-3p Pituitary adenoma MNDR-E-MI-11286
MNDR hsa-miR-132-3p Craniopharyngioma MNDR-E-MI-11287
MNDR hsa-miR-132-3p Lung squamous cell carcinoma MNDR-E-MI-11288
MNDR hsa-miR-132-3p Carcinoma lung non-small-cell MNDR-E-MI-11289
MNDR hsa-miR-132-3p Lung adenocarcinoma MNDR-E-MI-11290
MNDR hsa-miR-132-3p Thyroid carcinoma MNDR-E-MI-11291
MNDR hsa-miR-132-3p Ovarian carcinoma MNDR-E-MI-11292
MNDR hsa-miR-132-3p Bladder urothelial carcinoma MNDR-E-MI-11293
MNDR hsa-miR-132-3p Pancreatic adenocarcinoma MNDR-E-MI-11294
MNDR hsa-miR-132-3p Carcinoma renal cell MNDR-E-MI-11295
MNDR hsa-miR-132-3p Kidney renal papillary cell carcinoma MNDR-E-MI-11296
MNDR hsa-miR-132-3p Cholangiocarcinoma MNDR-E-MI-11297
MNDR hsa-miR-132-3p Esophageal cancer MNDR-E-MI-11298
MNDR hsa-miR-132-3p Encephalopathy bovine spongiform MNDR-E-MI-11299
MNDR hsa-miR-132-3p Synovial sarcoma MNDR-E-MI-11300
MNDR hsa-miR-132-3p T acute lymphoblastic leukemia MNDR-E-MI-11301
MNDR hsa-miR-132-3p Acute t cell leukemia MNDR-E-MI-11302
MNDR hsa-miR-132-3p Breast invasive carcinoma MNDR-E-MI-11303
MNDR hsa-miR-132-3p Juvenile rheumatoid arthritis MNDR-E-MI-11304
MNDR hsa-miR-132-3p Progressive supranuclear palsy MNDR-E-MI-11305
MNDR hsa-miR-132-3p Hepatocellular carcinoma MNDR-E-MI-11306
MNDR hsa-miR-132-3p Liver carcinoma MNDR-E-MI-11307
MNDR hsa-miR-132-3p Embryonal cancer MNDR-E-MI-11308
MNDR hsa-miR-132-3p B-cell non-hodgkin lymphoma MNDR-E-MI-11309
MNDR hsa-miR-132-3p Rheumatoid arthritis MNDR-E-MI-11310
MNDR hsa-miR-132-3p T-cell leukemia MNDR-E-MI-11311
MNDR hsa-miR-132-3p Malignant pleural mesothelioma MNDR-E-MI-11312
MNDR hsa-miR-132-3p Neuroblastoma MNDR-E-MI-11313
MNDR hsa-miR-132-3p Hodgkin lymphoma MNDR-E-MI-11314
MNDR hsa-miR-132-3p Burkitt lymphoma MNDR-E-MI-11315
MNDR hsa-miR-132-3p Neuromyelitis optica MNDR-E-MI-11316
MNDR hsa-miR-132-3p Acute myelogenous leukemia MNDR-E-MI-11317
MNDR hsa-miR-132-3p Frontotemporal dementia MNDR-E-MI-11318
MNDR hsa-miR-132-3p Colorectal cancer MNDR-E-MI-11319
MNDR hsa-miR-132-3p Nasopharynx carcinoma MNDR-E-MI-11320
MNDR hsa-miR-132-3p Ependymoma MNDR-E-MI-11321
MNDR hsa-miR-132-3p Nasopharyngeal cancer MNDR-E-MI-11322
MNDR hsa-miR-132-3p Sleep deprivation MNDR-E-MI-11323
MNDR hsa-miR-132-3p Toxoplasmosis cerebral MNDR-E-MI-11324
MNDR hsa-miR-132-3p Polymyositis MNDR-E-MI-11325
MNDR hsa-miR-132-3p Epstein-barr virus infections MNDR-E-MI-11326
MNDR hsa-miR-132-3p Subarachnoid hemorrhage traumatic MNDR-E-MI-11327
MNDR hsa-miR-132-3p Gait ataxia MNDR-E-MI-11328
MNDR hsa-miR-132-3p Lung injury MNDR-E-MI-11329
MNDR hsa-miR-132-3p Chronic pain MNDR-E-MI-11330
MNDR hsa-miR-132-3p Non-alcoholic fatty liver disease MNDR-E-MI-11331
MNDR hsa-miR-132-3p Breast cancer her3+ negative MNDR-E-MI-11332
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter AGO2 Homo sapiens RR00055673
TOP